Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-359676

Chief Medical Officer acquired 22,807 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bedrosian Camille L Chief Medical Officer 2026-08-18 Grant or award +22,807 288,092 D: show line 1 in the form
Loading xslF345X06/ownership.xml…